'''Octamoxin''' (trade names '''Ximaol''', '''Nimaol'''), also known as '''2-octylhydrazine''', is an [[irreversible inhibition|irreversible]] and [[binding selectivity|nonselective]] [[monoamine oxidase inhibitor]] (MAOI) of the [[hydrazine]] class that was used as an [[antidepressant]] in the 1960s but is now no longer marketed.<ref name="urlDictionary of pharmacological agents - Google Books">{{cite web | url = https://books.google.com/books?id=A0THacd46ZsC&lpg=PA1323&ots=IIjkfFzga1&dq=octamoxin%20ximaol&pg=PA1323#v=onepage&q=octamoxin%20ximaol&f=false | title = Dictionary of pharmacological agents - Google Books | format = | work = | accessdate = }}</ref><ref name="url13-06781. Octamoxin [Archived]: The Merck Index">{{cite web | url = http://www.medicinescomplete.com/mc/merck/2009/13-06781.htm | title = 13-06781. Octamoxin [Archived]: The Merck Index | work = | accessdate = }}</ref><ref name="pmid5925088">{{cite journal |vauthors=Levy J, Michel-Ber E | title = [Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice] | language = French | journal = Thérapie | volume = 21 | issue = 4 | pages = 929–45 | year = 1966 | pmid = 5925088 | doi = | url = }}</ref><ref name="pmid5976767">{{cite journal |vauthors=Gayral L, Stern H, Puyuelo R | title = [Indications and results of the treatment of mental depression by octamoxine (ximaol)] | language = French | journal = Thérapie | volume = 21 | issue = 5 | pages = 1183–90 | year = 1966 | pmid = 5976767 | doi = | url = }}</ref>
